Specifically in this experiment, SB demonstrated the ability to decrease the blood concentration of tumor specific markers such as CEA, TNF-alpha, IL-6 and liver function markers (including ALT and AST) in the treated groups. The gene discussed is IL6; the disease is neoplasm.